These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8754091)

  • 41. Peppermint oil and irritable bowel syndrome.
    Koch TR
    Am J Gastroenterol; 1998 Nov; 93(11):2304-5. PubMed ID: 9820429
    [No Abstract]   [Full Text] [Related]  

  • 42. [Multicenter study on the effectiveness and tolerance of a bromazepam + propantheline combination in patients with irritable bowel syndrome].
    Dioguardi N; Agape D; Antoniozzi F; Ballarin E; De Franchis R; Ferrari A; Fesce E; Grimoldi D; Pozzi M; Psilogenis M
    Minerva Dietol Gastroenterol; 1987; 33(2):155-67. PubMed ID: 2888056
    [No Abstract]   [Full Text] [Related]  

  • 43. Different therapeutic regimens in irritable bowel syndrome.
    Nigam P; Kapoor KK; Rastog CK; Kumar A; Gupta AK
    J Assoc Physicians India; 1984 Dec; 32(12):1041-4. PubMed ID: 6526796
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of irritable colon with a new pharmacological combination: clinical and psychological evaluation].
    Colombo E; Lampugnani E; Riva D
    Clin Ter; 1979 Jul; 90(2):165-71. PubMed ID: 43208
    [No Abstract]   [Full Text] [Related]  

  • 45. Diagnosis and care of irritable bowel syndrome in a community-based population.
    Yawn BP; Locke GR; Lydick E; Wollan PC; Bertram SL; Kurland MJ
    Am J Manag Care; 2001 Jun; 7(6):585-92. PubMed ID: 11439732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment with antidepressants in biliary dyskinesia and irritable colon].
    Birţ M; Dumitraşcu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(3):277-82. PubMed ID: 2573937
    [No Abstract]   [Full Text] [Related]  

  • 47. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study.
    Krymchantowski AV; Filho PF; Bigal ME
    Cephalalgia; 2006 Jul; 26(7):871-4. PubMed ID: 16776704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Irritable colon].
    Lindberg M
    Ugeskr Laeger; 2001 Oct; 163(41):5694. PubMed ID: 11665483
    [No Abstract]   [Full Text] [Related]  

  • 49. Role of pinaverium bromide in south Indian patients with irritable bowel syndrome.
    Jayanthi V; Malathi S; Ramathilakam B; Dinakaran N; Balasubramanian V; Mathew S
    J Assoc Physicians India; 1998 Apr; 46(4):369-71. PubMed ID: 11273320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Dysfunction of the Oddi's sphincter].
    Laugier R; Grandval P; Ville E
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C24-9. PubMed ID: 11787376
    [No Abstract]   [Full Text] [Related]  

  • 51. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.
    Bardhan KD; Forbes A; Marsden CL; Mason T; Short G
    Aliment Pharmacol Ther; 2004 Jul; 20(2):213-22. PubMed ID: 15233702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Irritable bowel syndrome: new approaches to its pharmacological management.
    Tougas G
    Can J Gastroenterol; 2001 Oct; 15 Suppl B():12B-13B. PubMed ID: 11694909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trimebutine: a state-of-the-art review.
    Salvioli B
    Minerva Gastroenterol Dietol; 2019 Sep; 65(3):229-238. PubMed ID: 31617696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alosetron for irritable bowel syndrome.
    Lièvre M
    BMJ; 2002 Sep; 325(7364):555-6. PubMed ID: 12228116
    [No Abstract]   [Full Text] [Related]  

  • 55. [Action of Poly-Karaya in functional colopathies. Results of a multicenter study of 114 patients].
    Dorf G; Licht H; Namias A; Paraf A
    Med Chir Dig; 1981; 10(6):533-8. PubMed ID: 7311642
    [No Abstract]   [Full Text] [Related]  

  • 56. Double blind trial of ispaghula/poloxamer in the Irritable Bowel Syndrome.
    Arthurs Y; Fielding JF
    Ir Med J; 1983 May; 76(5):253. PubMed ID: 6307924
    [No Abstract]   [Full Text] [Related]  

  • 57. Serotonin receptor modulation in irritable bowel syndrome: one step forwards and one step backwards.
    Whorwell PJ
    Gut; 2001 May; 48(5):596-7. PubMed ID: 11302953
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacologic therapy for the irritable bowel syndrome.
    Talley NJ
    Am J Gastroenterol; 2003 Apr; 98(4):750-8. PubMed ID: 12738451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The effect of Kaologeais in spastic colonic diseases].
    Heraud M
    Med Chir Dig; 1979; 8(3):263-5. PubMed ID: 534010
    [No Abstract]   [Full Text] [Related]  

  • 60. [Proxybarbital (Ipronal) in the pathogenetic treatment of irritable bowel syndrome].
    Knapik Z; Lubczyńska-Kowalska W; Paradowski L; Szczeklik-Selinger E
    Pol Tyg Lek; 1983 Sep; 38(36):1105-7. PubMed ID: 6144092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.